Coronavirus likely to sideline 2020 policy changes for prescription pricing and 340B, while Medicare Part B reimbursement changes continue as planned The coronavirus (COVID-19) outbreak…
Plan sponsors are concerned about the turbulence in the prescription drug marketplace, particularly the recent alliances between major PBMs and insurers. Since …
The Big Three Pharmacy Benefit Managers (OptumRx, Express Scripts, CVS Caremark) released updates to their 2020 formulary exclusions, and our analysis shows that member impact…
With drug costs continually escalating, health plans need to capture every available dollar to reduce their overall healthcare expenditures. One way to realize value is…
When it comes to copay accumulators,patient impact – not final rule – should drive plan sponsor’s strategy As additional guidance is provided, we’ll continue to…
Drug cost management is a top priority for plan sponsors. It’s no wonder, then, that the concept of eliminating waste from plan formularies has widespread…
Plan sponsors are constantly waging a war on unnecessary drug spend and waste due to the inclusion of non-essential drugs on their PBM’s formulary or preferred…
PSG recognizes our responsibility as good corporate citizens is, in part, to help enrich our surrounding areas of residence and work by positively impacting quality…